Skip to main content
OpenTrials

Clinical trial condition

Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma

Explore clinical trials studying Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma trial results

Recruiting

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

NCT07148128

Conditions
Advanced Solid Tumors, Advanced or Metastatic KRAS-mutant Tumor, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, +28 more
Locations
  • NEXT Oncology Dallas Dallas, Texas, United States
  • Next Oncology, San Antonio San Antonio, Texas, United States
  • Princess Margareth Cancer Center Toronto, Ontario, Canada
  • Oxford University Hospital Headington, Oxford, United Kingdom
View Trial Details

Related conditions